Edition:
India

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,540JPY
22 Mar 2019
Change (% chg)

¥-22 (-1.41%)
Prev Close
¥1,562
Open
¥1,560
Day's High
¥1,563
Day's Low
¥1,537
Volume
399,800
Avg. Vol
355,560
52-wk High
¥1,907
52-wk Low
¥1,507

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 23 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 2 2 2
(3) HOLD 3 3 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.60 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 40,276.00 40,276.00 40,276.00 --
Year Ending Mar-19 5 169,460.00 170,900.00 167,500.00 203,975.00
Year Ending Mar-20 5 204,240.00 210,000.00 194,600.00 216,600.00
Earnings (per share)
Year Ending Mar-19 6 121.53 138.23 89.11 127.36
Year Ending Mar-20 6 134.10 146.63 115.88 148.93
LT Growth Rate (%) 1 1.32 1.32 1.32 --

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 45,154.00 44,878.00 276.00 0.61
Quarter Ending Sep-18 41,222.00 40,068.00 1,154.00 2.80
Quarter Ending Jun-18 40,300.00 42,278.00 1,978.00 4.91
Quarter Ending Sep-17 51,487.00 45,784.00 5,703.00 11.08
Quarter Ending Mar-17 50,425.00 46,097.00 4,328.00 8.58

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 40,276.00 40,276.00 40,276.00 40,000.00 --
Year Ending Mar-19 169,460.00 169,460.00 169,650.00 169,250.00 203,975.00
Year Ending Mar-20 204,240.00 204,240.00 202,800.00 202,300.00 216,600.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings